Lantern Pharma Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by Lantern Pharma Inc. on June 8, 2022. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol LTRN. The filing was signed on June 14, 2022.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
The primary event reported is the election of six directors and the ratification of the independent auditor. All six nominees were elected to the board of directors. Notably, director Vijay Chandru received a significantly higher number of withheld votes compared to other nominees.
| Director Nominee | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Donald Jeff Keyser | 3,851,243 | 17,949 | 3,672,511 |
| Panna Sharma | 3,852,250 | 16,942 | 3,672,511 |
| Vijay Chandru | 3,181,861 | 687,331 | 3,672,511 |
| Maria Maccecchini | 3,851,129 | 18,063 | 3,672,511 |
| Franklyn Prendergast | 3,850,969 | 18,223 | 3,672,511 |
| David S. Silberstein | 3,850,689 | 18,503 | 3,672,511 |
Stockholders also ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022. The vote totals were 7,482,954 For, 18,585 Against, and 40,164 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Director Support Disparity: Verify the reason for the high number of withheld votes (687,331) for director Vijay Chandru compared to the other five nominees, who each received fewer than 19,000 withheld votes.
- Broker Non-Votes: Note that approximately 3.67 million shares were recorded as broker non-votes for all director elections, indicating a significant portion of shares held in street name were not voted on these matters.
- Auditor Ratification: Confirm the continued engagement of EisnerAmper LLP for the 2022 fiscal year, which was approved by a strong majority of voting shares.